Animal Health
May 2013
13/05/13
Bioniche Engages Evercore Partners to Assist in the Divestment of its Animal Health Business
April 2013
18/04/13
Bioniche E. coli O157 Vaccine to be Used in an On-Farm Intervention Study in Sweden
March 2013
27/03/13
Bioniche Life Sciences Inc. Receives Government of Canada Support for Second Generation E. coli O157 Vaccine
January 2013
24/01/13
Bioniche Life Sciences Inc. Launches Two New Animal Health Products in Canada
December 2012
13/12/12
Bioniche Life Sciences Inc. Achieves Registration of Enhance™ I.A./I.V. in Hong Kong
04/12/12
Bioniche Life Sciences Inc. Launches NexHA™ in Canada
November 2012
21/11/12
U.S. Distributor Appointed for Bioniche’s ImmunocidinTM Canine Oncology Therapy
October 2012
17/10/12
Bioniche Life Sciences Inc. Announces North American Market Launch of ImmunocidinTM
September 2012
20/09/12
Bioniche Life Sciences Inc. Discovers a Counterfeit Equine Product
August 2012
20/08/12
Bioniche Launches New U.S. Equine Product and Acquires Canadian Distribution Rights to Six Additional Products
13/08/12
Bioniche Life Sciences Inc. Enters into an Exclusive U.S. Distribution Agreement for an Equine Product
07/08/12
Special Treatment Certificate Issued for Importation of E. coli O157 Vaccine into the United Kingdom
July 2012
31/07/12
Bioniche Presents Preliminary Data on the Use of In-Licensed Superagonist Hormone Technology in Cattle
23/07/12
Bioniche Life Sciences Inc. Moves Closer to Market Launch of ImmunocidinTM
May 2012
01/05/12
Bioniche Life Sciences Inc. Commercializing Two Products for Canine Cancer
April 2012
18/04/12
Bioniche Life Sciences Inc. Sponsors Two Major International Livestock Reproduction Conferences
March 2012
23/03/12
Bioniche Life Sciences Inc. Enters into a Distribution Agreement for New Animal Health Products in Australia
December 2011
21/12/11
Bioniche Life Sciences Inc. Enters into Two Distribution Agreements for New Animal Health Products
13/12/11
Bioniche E. coli Vaccine Granted Import Access to Australia
October 2011
27/10/11
Bioniche Life Sciences Inc. Receives Canadian Regulatory Approval for Equine Anti-Inflammatory Product
June 2011
13/06/11
Bioniche Chief Veterinary Scientific Officer Discusses Vaccine Against E. coli O157 at International Meat Industry Conference
May 2011
05/05/11
Econiche™ Vaccine Efficacy Challenge Study Summarized in The Canadian Journal of Veterinary Research
April 2011
29/04/11
Animal Health and Food Safety Vaccine Manufacturing Centre Officially Opens in Belleville, Ontario, Canada
March 2011
22/03/11
Bioniche Life Sciences Inc. Keynote Speaker at 7th Annual NZBIO Conference in New Zealand
November 2010
30/11/10
Bioniche Obtains Exclusive U.S. Rights to Equine Reproductive Product from CreoSalus
15/11/10
Bioniche Presents at U.S. Animal Health Association Committee on Food & Feed Safety
October 2010
18/10/10
Bioniche Scientists Present at Modern Vaccine & Adjuvant Formulation Conference in France
June 2010
23/06/10
Bioniche & Trophogen Sign Exclusive Global Veterinary License Agreement for Superagonist Hormone Technology Platform
02/06/10
Bioniche Animal Health Partners with Bayer Australia to Distribute Livestock Product Line
September 2007
06/09/07
Bioniche Responds to Australian Equine Influenza Outbreak
April 2007
03/04/07
Non-Antibiotic Treatment for Equine Endometritis Study Data Published in International Peer-Reviewed Journal
June 2006
05/06/06
Counterfeit Product Linked to Death of Ontario Horse
03/06/05
New Studies Demonstrate Immunomodulatory Activity of Bioniche Technology in Dogs
May 2005
24/05/05
Bioniche Mycobacterial Cell Wall Extract (MCWE) Granted New Patent for Production Performance in Animals
March 2005
07/03/05
Research Shows Promise for Easy, Effective Management of Sow Breeding
January 2005
21/01/05
Bioniche Receives Authorization to Market Folltropin®-V in Additional EU Countries
December 2004
03/12/04
Livestock Revolution in Global Agriculture
November 2004
29/11/04
New Treatment for Equine Endometritis Given USDA Approval
August 2004
06/08/04
Mycobacterial Cell Wall Formulation Shows Promise in Treating Equine Endometritis
03/08/04
Bomac Laboratories Ltd. to Distribute Bioniche Cue-Mate® Technology in New Zealand
June 2004
21/06/04
Bioniche Commences Sales of Cue-Mate® Animal Reproductive Technology in Australian Cattle Market
18/06/04
Bioniche Receives Approval For New Animal Health Product Indication
10/06/04
Bioniche Presents Positive Data on Anti-Cancer Activity of MCC at 22nd Annual Meeting of American College of Veterinary Internal Medicine
April 2004
19/04/04
Bioniche Acquires Cue-Mate® Reproductive Technology From Pfizer
January 2004
10/01/04
Bioniche Life Sciences and AB Technology Sign Purchase Agreement
|
